SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the integrated hardware and software infrastructure of the future across space, connectivity, and AI. at core, are builders. The firm design, manufacture, launch, and operate products and services built on cutting-edge technologies, including the world’s most advanced rockets and spacecraft. It provides satellite communication services. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is generating massive market buzz following its high-profile public debut, with investors deeply divided over whether the company's multi-trillion dollar valuation reflects revolutionary long-term potential or unsustainable hype. The community is actively debating the stock's future, as traders closely monitor high volatility and look ahead to upcoming options trading, index inclusion, and the potential impact of insider lock-up expirations.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is trending following a Bloomberg report that the streaming company is exploring a potential sale, with discussions reportedly underway with at least one major U.S. media entity. The community is actively debating the credibility of these buyout rumors and the company's long-term strategic value, leading to significant volatility as traders analyze the potential for a premium acquisition against the backdrop of an increasingly competitive streaming landscape.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean Ltd. is currently trending as investors weigh strong backlog growth and improved operational efficiency against geopolitical uncertainty in the Strait of Hormuz. The community is actively debating whether the stock's recent performance is tethered more to daily fluctuations in oil prices or the long-term potential of its merger with Valaris and ongoing debt reduction efforts.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors debate the potential for future adoption versus extreme price volatility and frustration over a lack of major updates from the Flexa team. While community sentiment is heavily polarized between long-term holders citing the utility of the Anvil and Flexa ecosystem and critics pointing to the token's persistent downward trend, active discussions remain focused on legislative catalysts like the CLARITY Act and alleged institutional activity in staking pools.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

SPRY is surging as investors react to a significant regulatory delay for its primary competitor, Aquestive Therapeutics, effectively extending SPRY's lead as the only approved needle-free epinephrine treatment. The community is actively discussing a potential short squeeze, fueled by high short interest and institutional accumulation, as the company scales its global market presence.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is experiencing heightened interest as investors weigh record-high Nasdaq levels against volatile geopolitical developments, including U.S.-Iran tensions. The community is actively debating the sustainability of the AI-driven tech rally and the risks associated with holding triple-leveraged instruments in an environment characterized by inflation concerns and potential policy shifts.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

TROLL is capturing significant community attention as investors position it alongside established meme coins, with many touting its long-standing cultural relevance and potential for exponential growth. Enthusiasm is centered on the project's ownership of original IP rights and active grassroots campaigns aimed at driving massive adoption within the broader meme ecosystem.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is facing intense retail volatility as investors weigh its role as a key enterprise AI player against recent price consolidation and the market's broader rotation toward speculative IPOs and sector de-leveraging. The community remains deeply polarized, with many long-term holders treating recent pullbacks as prime accumulation zones while vocal detractors criticize the stock's valuation and the broader software sector's recent weakness.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as the community closely monitors the progress of its $110 billion acquisition of Warner Bros. Discovery following the Department of Justice's approval. Shareholders are actively debating the potential for long-term synergy value, the impact of ongoing regulatory reviews in Europe, and the strategic implications of management's integration plans while remaining focused on upcoming deal closing milestones.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors focus on a pending Supreme Court case regarding induced infringement, while actively debating the long-term impact of new cardiovascular guidelines and the company's path toward sustainable cash flow. Community discussion remains polarized, centering on the potential for a strategic buyout, the significance of the 2026 guideline updates, and skepticism regarding board management following the company's recent reverse split and financial restructuring.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IBRX and the BCG Shortage: Deals That Could Expand Demand

ImmunityBio targets the BCG shortage with new supply deals and label expansion efforts that could strengthen Anktiva demand in bladder cancer.

What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge

Key PointsSuperstring Capital sold 330,983 shares of UroGen Pharma Ltd last quarter; the estimated transaction value was $6.64 million based on quarterly average pricing...

Urogen Pharma (URGN) Just Flashed Golden Cross Signal: Do You Buy?

Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?

Urogen Pharma (NASDAQ:URGN) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Urogen Pharma (NASDAQ:URGN - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.47) earnings per share for the quarter, topping analysts' consensus estimates of ($0.48) by $0.01. The company had revenue of $50.96 million for the quarter, compared to analyst...

Urogen Pharma (NASDAQ:URGN) Trading Up 14% on Better-Than-Expected Earnings

Urogen Pharma (NASDAQ:URGN) Trading 14% Higher Following Better-Than-Expected Earnings...

Urogen Pharma (URGN) Reports Q1 Loss, Beats Revenue Estimates

Urogen Pharma (URGN) delivered earnings and revenue surprises of +16.44% and +16.96%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Beats Revenue Estimates

Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of +16.13% and +14.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Urogen Pharma (URGN) Projected to Post Quarterly Earnings on Wednesday

Urogen Pharma (NASDAQ:URGN) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-urogen-pharma-ltd-stock...

IBRX: What Anktiva's Bladder Data Says About 2026 Sales

ImmunityBio heads into 2026 riding Anktiva growth, but upcoming bladder trial data and broader use in earlier care will be key to sustaining momentum.

HC Wainwright Predicts Urogen Pharma Q1 Earnings

Urogen Pharma (NASDAQ:URGN - Free Report) - Stock analysts at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for shares of Urogen Pharma in a report issued on Thursday, April...

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

Current Price	$29.72
Prev Close	$29.50
Open	$29.48
Dividend Yield	0.00%
50-Day Moving Average	$25.69
Beta	1.13
Avg. Volume	935,641.02
PE Ratio	-10.79

52-Week High	$32.37
52-Week Low	$12.61
Market Capitalization	$1.44B
EPS (Annual)	-$3.19
Price to Book	-11.65
Revenue Per Employee	$377,278.35

URGNUroGen Pharma Ltd

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest URGN News